References
- Heulin M H, Rajoelina J, Lasbennes A, Lamotte F, Straczek J, Gelot M A, Arthur M, Belleville F, Nabet P. Isolation and characterization of a low molecular weight growth promoting factor from human plasma. Life Sci 1987; 41: 297–304
- Froesch E R, Zapf J, Andhya T K, Ben Porath E, Segen B J, Gibson K D. Nonsuppressible insulin-like activity and thyroid hormone. Major pituitary-dependent sulphation factors for chick embryo cartilage. Proc Natl Acad Sci USA 1976; 73: 2904–2908
- Silbergeld A, Mamet R, Lazou Z, Nevo Z. The effect of insulin-like growth factor and of human serum on steps in proteoglycan synthesis. Acta Endocrinol (Copenh) 1981; 97: 503–507
- Heulin M H, Artur M, Malaprade D, Straczek J, Pierson M, Stoltz J F, Belleville F, Paysant P, Nabet P. Evidence for the presence in human serum of an ultrafiltrable factor activating somatomedins. Biochem Biophys Res Commun 1981; 99: 644–653
- Jacob C, Maachi F, El Farricha O, Dousset B, Kessler M, Belleville F, Nabet P. Role of the kidney in the expression of low molecular weight factors with growth factor activity. Clin Nephrol 1993; 39: 327–333
- Phillips L S, Fusco Ac, Unterman T G, Del Greco F. Somatomedin inhibitor in uremia. J Clin Endocrinol Metab 1984; 59: 764–772
- Hall K. Quantitative determination of the sulphation factor activity in human serum. Acta Endocrinol (Copenh) 1970; 63: 338–350
- Schimpff R M, Donnadieu M. Quantitative determination of somatomedin in human serum. Biomedicine 1973; 19: 142–147
- Heulin M H, Artur M, Geschier C, Straczek J, Vescovi G, Belleville F, Paysant P, Nabet P. The biological assay of human somatomedin A: improvement by small molecular weight natural molecules. Acta Endocrinol (Copenh) 1984; 106: 43–51
- Coles E H. Le laboratoire en clinique vétérinaire. Vigot, Paris 1979; 641
- Hitz J, Devaux F, Galli F, Siert G, Kiechel J R. Valeurs de référence des constituants chimiques et des enzymes plasmatiques chez le miniporc. Ann Biol Clin 1987; 45: 532–536
- Fortyn K, Hruban V, Hradecky J, Horak V. Changes of clinical biochemical values after bilateral nephrectomy and allotransplantation of kidney in pigs. Int Urol Nephrol 1988; 20: 299–305
- Bozovic L J, Boström H, Bozovic M, Lundin L. Inhibition of 35SO4 incorporation by a fraction of normal urine. Acta Endocrinol suppl 1975; 199: 117
- Philips L S, Goldstein S, Klein J D, Sulinski C M, El-Kebbi I M, Ziemer D C, Pollet R J, Stults J. Uremic serum growth inhibitor (abstract). Clin Res 1990; 38: 33A
- Andress D L, Howard G A, Birnbaum R S. Identification of a low molecular weight inhibitor of osteoblast mitogenesis in uremic plasma. Kidney Int 1991; 39: 942–945
- Taylor A M, Sharma A K, Avasthy N, Duguid I GM, Blanchard D S, Thomas P K, Dandona P. Inhibition of somatomedin-like activity by serum from streptozotocin-diabetic rats: prevention by insulin treatment and correlation with skeletal growth. Endocrinology 1987; 121: 1360–1365
- Anderson G, Skottner A, Jennische E. Immunocytochemical localisation of insulin-like growth factor I in the kidney of rats before and after uninephrectomy. Acta Endocrinol 1988; 119: 555–560
- D'Ercole A J, Stiles A D, Underwood L E. Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanism of action. Proc Natl Acad Sci USA 1984; 81: 935–939
- Schwieger J, Fine L G. Renal hypertrophy, growth factors and nephropathy in diabetes mellitus. Semin Nephrol 1990; 10: 242–253
- Segal R, Fine L G. Polypeptide growth factors and the kidney. Kidney Int 1989; 36(suppl 27)S2–S10